Literature DB >> 1375826

Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration.

S B Bressler1, J C Silva, N M Bressler, J Alexander, W R Green.   

Abstract

We report the clinicopathologic features of an eye with occult choroidal neovascularization associated with age-related macular degeneration. Ophthalmoscopic findings at presentation included subretinal fluid and lipid. We noted angiographic staining of irregularly elevated areas of retinal pigment epithelium. In the late phase of the angiogram, fluorescein leakage at the level of the outer retina was observed that did not correspond to well-demarcated areas of hyperfluorescence in earlier phases. The patient was randomized to treatment in a pilot trial comparing the effects of grid laser treatment with the effects of no treatment for occult choroidal neovascularization. Three weeks after treatment, some of the subretinal fluid had cleared and vision improved. The patient died 6 weeks after laser treatment. Histopathologic study disclosed a subretinal pigment epithelial fibrovascular membrane. Neovascularization originated from the choroid.

Entities:  

Mesh:

Year:  1992        PMID: 1375826     DOI: 10.1001/archopht.1992.01080180099035

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Grid laser treatment of occult choroidal neovascularization in age related macular degeneration.

Authors:  F Cardillo Piccolino; D Ghiglione; P Allegri
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

2.  High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration.

Authors:  Susanna S Park; Steven N Truong; Robert J Zawadzki; Suhail Alam; Stacey S Choi; David G Telander; John S Werner; Lawrence S Morse
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

3.  Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration.

Authors:  A Jaakkola; J Heikkonen; P Tommila; L Laatikainen; I Immonen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

4.  Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation.

Authors:  B A Lafaut; K U Bartz-Schmidt; C Vanden Broecke; S Aisenbrey; J J De Laey; K Heimann
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

5.  The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning.

Authors:  Robert F Mullins; Desi P Schoo; Elliott H Sohn; Miles J Flamme-Wiese; Grefachew Workamelahu; Rebecca M Johnston; Kai Wang; Budd A Tucker; Edwin M Stone
Journal:  Am J Pathol       Date:  2014-09-07       Impact factor: 4.307

6.  [Does acetylsalicylic acid have a negative influence on photodynamic therapy?].

Authors:  U Löw; J K Kohlhof; K W Ruprecht
Journal:  Ophthalmologe       Date:  2006-03       Impact factor: 1.059

7.  Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  J Arnold; M Algan; G Soubrane; G Coscas; E Barreau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

8.  Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase.

Authors:  Susan G Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

9.  A hyporeflective space between hyperreflective materials in pigment epithelial detachment and Bruch's membrane in neovascular age-related macular degeneration.

Authors:  Ryo Mukai; Taku Sato; Shoji Kishi
Journal:  BMC Ophthalmol       Date:  2014-12-16       Impact factor: 2.209

Review 10.  Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II.

Authors:  J Fernando Arevalo; Andres F Lasave; Juan D Arias; Martin A Serrano; Fernando A Arevalo
Journal:  Clin Ophthalmol       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.